Argyle Capital Management Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Argyle Capital Management Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$404,894
+0.9%
3,9750.0%0.15%
+2.1%
Q2 2023$401,117
-27.9%
3,975
-34.3%
0.14%
-26.0%
Q1 2023$556,600
+1.4%
6,0500.0%0.20%
+3.7%
Q4 2022$548,856
+19.3%
6,0500.0%0.19%
+5.6%
Q3 2022$460,000
-10.0%
6,0500.0%0.18%
-2.2%
Q2 2022$511,000
-3.8%
6,0500.0%0.18%
+5.8%
Q1 2022$531,000
+0.4%
6,0500.0%0.17%
+4.8%
Q4 2021$529,000
+6.9%
6,0500.0%0.16%
+0.6%
Q3 2021$495,000
-10.3%
6,0500.0%0.16%
-7.9%
Q2 2021$552,000
+6.8%
6,0500.0%0.18%
+2.3%
Q1 2021$517,000
-9.5%
6,0500.0%0.17%
-18.3%
Q4 2020$571,000
-16.0%
6,050
-22.7%
0.21%
-23.7%
Q3 2020$680,000
-9.7%
7,825
-9.3%
0.28%
-11.7%
Q2 2020$753,000
+5.9%
8,6250.0%0.32%
-6.0%
Q1 2020$711,000
-13.0%
8,6250.0%0.34%
+15.9%
Q4 2019$817,000
+8.9%
8,6250.0%0.29%
+2.5%
Q3 2019$750,000
-4.8%
8,6250.0%0.28%
-5.4%
Q2 2019$788,000
-4.9%
8,6250.0%0.30%
-6.3%
Q1 2019$829,000
+12.0%
8,6250.0%0.32%
+1.9%
Q4 2018$740,000
-0.4%
8,6250.0%0.31%
+12.6%
Q3 2018$743,000
+14.0%
8,6250.0%0.28%
+7.3%
Q2 2018$652,000
-10.7%
8,625
-4.4%
0.26%
-10.4%
Q1 2018$730,000
-3.7%
9,0250.0%0.29%
+1.8%
Q4 2017$758,000
-2.2%
9,0250.0%0.28%
-6.6%
Q3 2017$775,000
+2.9%
9,0250.0%0.30%
-0.7%
Q2 2017$753,000
+12.4%
9,0250.0%0.31%
+12.1%
Q1 2017$670,000
+1.2%
9,025
-0.6%
0.27%
-2.8%
Q4 2016$662,000
-7.7%
9,0830.0%0.28%
-9.6%
Q3 2016$717,000
-6.4%
9,083
-2.2%
0.31%
-4.3%
Q2 2016$766,000
+14.0%
9,2830.0%0.32%
+6.6%
Q1 2016$672,000
-15.9%
9,2830.0%0.30%
-17.1%
Q4 2015$799,000
-6.3%
9,2830.0%0.37%
-11.8%
Q3 2015$853,000
-8.6%
9,283
-2.1%
0.42%
-2.3%
Q2 2015$933,000
-3.7%
9,483
-3.5%
0.43%
-1.4%
Q1 2015$969,000
+6.5%
9,8250.0%0.43%
+8.5%
Q4 2014$910,000
-1.6%
9,8250.0%0.40%
-6.3%
Q3 2014$925,000
+4.0%
9,8250.0%0.43%
+2.7%
Q2 2014$889,000
+6.5%
9,8250.0%0.42%
+1.2%
Q1 2014$835,000
+5.7%
9,8250.0%0.41%
+3.0%
Q4 2013$790,000
+4.8%
9,8250.0%0.40%
-3.9%
Q3 2013$754,000
+6.3%
9,825
-2.0%
0.41%
+2.0%
Q2 2013$709,00010,0250.41%
Other shareholders
NOVARTIS A G shareholders Q1 2021
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders